New Devices and Technologies for the Management of Overactive Bladder

Guzman-Negron, Juan M.; Goldman, Howard B.

doi:10.1007/s11934-017-0739-y

Cited by 13 publications

(15 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Bioness StimRouter is a custom-made lead transcutaneously powered by an external pulse generator (EPG). A receiver, electrodes, and an anchoring system are all included in the implanted lead [ 60 ]. During implantation, ultrasound or fluoroscopic imaging may aid with the stimulation probes' placement, which is used to test stimulation to ensure proper peripheral nerve targeting.…”

Section: Posterior Tibial Nerve Stimulation Classificationsmentioning

confidence: 99%

Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines

Al-Danakh

Safi

Alradhi

et al. 2022

Parkinson's Disease

View full text Add to dashboard Cite

Purpose of the Review. Posterior tibial nerve stimulation (PTNS) techniques have dramatically grown after approval to manage overactive bladder (OAB). The present review will focus on the most current data on PTNS types (percutaneous, transcutaneous, and implant) and their mechanism of action, safety, efficacy, advantages, drawbacks, limitation, and clinical applications. Recent Findings. The present review described the recent studies that addressed the tibial nerve stimulation role in OAB management. BlueWind RENOVA system, Bioness StimRouter, and eCoin are examples of emerging technologies that have evolved from interval sessions (percutaneous PTNS and transcutaneous PTNS) to continuous stimulation (implants). These can be efficiently managed at home by patients with minimum burden on the health system and fewer visits, especially in the COVID-19 pandemic. Summary. Our review shows that the tibial nerve stimulation advancements in OAB treatment have been rapidly increasing over the recent years. It is minimally invasive and effective, similar to sacral nerve stimulation (SNM), but less aggressive. Implantable PTNS has been promised in terms of efficacy, safety, and high acceptance rate. However, evidence is still limited to short-term trials, and tolerability, method, and drawbacks remain challenges.

show abstract

Section: Posterior Tibial Nerve Stimulation Classificationsmentioning

confidence: 99%

Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines

Al-Danakh

Safi

Alradhi

et al. 2022

Parkinson's Disease

View full text Add to dashboard Cite

show abstract

“…Studies have shown that within a year, between 30% and 70% of patients with OAB discontinue pharmacotherapy [82,83]. Hence, various stimulation devices are an alternative next-in-line treatment option for OAB and although they are more invasive, they have shown better improvement for OAB [53].…”

Section: Nerve Stimulation Devicesmentioning

confidence: 99%

“…Clinically approved and research-based electronic device solutions for overactive bladder (OAB), underactive bladder (UAB) and other-urinary-affecting disorders (OUAD). Clinically approved electronic solutions include InterStim [40], Axonics modulation technologies [53], inFlow [39], robotic surgery [54,55], ultrasonography systems [56,57] and near-infrared spectroscopy [58].…”

Section: Introductionmentioning

confidence: 99%

Advances in Assistive Electronic Device Solutions for Urology

et al. 2022

View full text Add to dashboard Cite

Recent technology advances have led urology to become one of the leading specialities to utilise novel electronic systems to manage urological ailments. Contemporary bladder management strategies such as urinary catheters can provide a solution but leave the user mentally and physically debilitated. The unique properties of modern electronic devices, i.e., flexibility, stretchability, and biocompatibility, have allowed a plethora of new technologies to emerge. Many novel electronic device solutions in urology have been developed for treating impaired bladder disorders. These disorders include overactive bladder (OAB), underactive bladder (UAB) and other-urinary-affecting disorders (OUAD). This paper reviews common causes and conservative treatment strategies for OAB, UAB and OUAD, discussing the challenges and drawbacks of such treatments. Subsequently, this paper gives insight into clinically approved and research-based electronic advances in urology. Advances in this area cover bladder-stimulation and -monitoring devices, robot-assistive surgery, and bladder and sphincter prosthesis. This study aims to introduce the latest advances in electronic solutions for urology, comparing their advantages and disadvantages, and concluding with open problems for future urological device solutions.

show abstract

“…SNS is performed with a stimulator and electrodes implanted on sacral nerves 2-4 which provide continuous stimulation to the nerve. SNS implants were initially introduced to the market by Medtronic as InterStim, and since then, Axonics Modulation Technologies Inc (Irvine, CA, USA) have developed smaller and rechargeable implants [136]. SNS has been trialed in a number of studies to improve symptoms and quality of life in constipation, but the evidence that SNS is effective for constipation is limited [137,138].…”

Section: Therapiesmentioning

confidence: 99%

Bioelectrical Signals for the Diagnosis and Therapy of Functional Gastrointestinal Disorders

et al. 2020

View full text Add to dashboard Cite

Coordinated contractions and motility patterns unique to each gastrointestinal organ facilitate the digestive process. These motor activities are coordinated by bioelectrical events, sensory and motor nerves, and hormones. The motility problems in the gastrointestinal tract known as functional gastrointestinal disorders (FGIDs) are generally caused by impaired neuromuscular activity and are highly prevalent. Their diagnosis is challenging as symptoms are often vague and difficult to localize. Therefore, the underlying pathophysiological factors remain unknown. However, there is an increasing level of research and clinical evidence suggesting a link between FGIDs and altered bioelectrical activity. In addition, electroceuticals (bioelectrical therapies to treat diseases) have recently gained significant interest. This paper gives an overview of bioelectrical signatures of gastrointestinal organs with normal and/or impaired motility patterns and bioelectrical therapies that have been developed for treating FGIDs. The existing research evidence suggests that bioelectrical activities could potentially help to identify the diverse etiologies of FGIDs and overcome the drawbacks of the current clinically adapted methods. Moreover, electroceuticals could potentially be effective in the treatment of FGIDs and replace the limited existing conventional therapies which often attempt to treat the symptoms rather than the underlying condition.

show abstract

New Devices and Technologies for the Management of Overactive Bladder

Cited by 13 publications

References 8 publications

Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines

Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines

Advances in Assistive Electronic Device Solutions for Urology

Bioelectrical Signals for the Diagnosis and Therapy of Functional Gastrointestinal Disorders

Contact Info

Product

Resources

About